IMR Press / FBE / Volume 1 / Issue 2 / DOI: 10.2741/E44

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Quality of life in patients with meningiomas: the true meaning of "benign"
Show Less
1 Advanced Practice Nursing Group, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, 350 W. Thomas Road, Phoenix, Arizona 85013, USA
Academic Editor:Nicholas C. Bambakidis
Front. Biosci. (Elite Ed) 2009, 1(2), 488–493;
Published: 1 June 2009
(This article belongs to the Special Issue Intracranial meningiomas - a critical review)

Health-related quality of life (QOL) is a complex subject that requires assessment of patients' perceptions about their lives after surgery or illness in addition to the perceptions of surgeons about outcomes and radiographic findings. Patients should be asked about the effect of the disease on their work life, relationships, emotional and physical well being, and level of independence. Even the limited available literature makes it clear that the course of treatment of patients with meningiomas can be anything but benign. Future research is required using global QOL scales and disease-specific scales. Because QOL is a multidimensional concept, researchers must select the appropriate QOL scale that best measures the appropriate dimension of health (physical function, emotional well being, and symptoms). This article provides a review of current research on QOL related to the surgical treatment of meningiomas to help increase clinicians' understanding of the complex nature of QOL assessment and how this assessment can be applied to neurosurgical patients.

Back to top